STLN
The Oncology Institute, Inc.
6.40$
-2.3%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|
| 1.17 | 1.28 | 1.40 | 1.40 | 1.45 | 1.57 | 5.70 | |
| 0.98 | 1.10 | 1.21 | 1.17 | 1.22 | 1.30 | 4.81 | |
| 0.19 | 0.19 | 0.19 | 0.22 | 0.23 | 0.26 | 0.89 | |
| 0.29 | 0.29 | 0.26 | 0.28 | 0.28 | 0.29 | 1.08 | |
| 1.29 | 1.40 | 0.28 | 0.29 | 0.29 | 0.31 | 1.15 | |
| -0.11 | -0.12 | -0.08 | -0.07 | -0.06 | -0.04 | -0.25 | |
| 0.06 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.07 | |
| -0.22 | -0.18 | -0.17 | -0.07 | -0.02 | -0.10 | -0.35 | |
| -0.22 | -0.18 | -0.17 | -0.07 | -0.02 | -0.10 | -0.35 | |
| – | -0.14 | -0.13 | -0.04 | 0.01 | -0.06 | -0.21 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.